Annual Report 2022
Division of Surveillance and Policy Evaluation
Kota Katanoda, Kayo Togawa, Hirokazu Tanaka, Sayaka Ikeda, Sayo Tanaka, Nguyen The Phuong, Palmer Matthew, Hiroko Takamatsu, Reiko Sakano, Takako Kojima, Kayo Sone
Introduction
The Division of Surveillance and Policy Evaluation develops and analyzes comprehensive cancer statistics information including cancer registry data to contribute to the development and evaluation of evidence-based cancer control.
The Team and What We Do
With the aim to clarify the cancer burden in our society and realize optimal cancer control policies, our research focuses on descriptive epidemiology and policy evaluation by leveraging national and international cancer statistics, geographic information systems (GISs), and other sources of information. More specifically, we describe cancer trends, geographical patterns, prevention, screening, and other phases of the cancer control continuum, and also evaluate cancer control measures using mathematical approaches such as simulation modelling and health economics.
Research Activities
1. Cancer statistics website "Cancer Information Service"
Cancer statistics data and graphical information such as cancer incidence, mortality and survival are provided on the website “Cancer Information Service”, managed by Institute for Cancer Control. Our analysis using cancer statistics information is published as a scientific publication in the Japanese Journal of Clinical Oncology (JJCO) and other academic journals. For the general public, the booklet "Cancer Statistics" is also published annually. This fiscal year, we provided cancer mortality data for 2021 and cancer incidence data for 2019 and published the booklet "Cancer statistics in Japan 2023".
2. Research on cancer statistics and cancer control
Cancer statistics information is analyzed and combined with information on cancer prevention, early detection, diagnosis, treatment, palliative care, and health economics to develop and evaluate cancer control policies. This fiscal year, we performed the long-term projections of cancer incidence and mortality, trend analysis of cervical cancer, analysis of genotype-specific prevalence of human papillomavirus, and estimation of the effect of comprehensive tobacco control policies.
3. Others
Our research activities also cover a variety of analysis on cancer and life-style related diseases prevention, early detection, treatment, etc. In this fiscal year, the effects of COVID-19 pandemic on health behaviors were examined.
Education
Graduate students were openly recruited in our division under the framework of a joint graduate school in the field of Cancer Statistics and Informatics in collaboration with Osaka University Graduate School of Medicine. Job training opportunities were provided for graduate students at the School of Public Health, St. Luke's International University in the scope of setting up a future joint graduate school program.
Future Prospects
Based on the development and analysis of cancer statistics information, we aim to realize effective and efficient cancer control measures through the cancer control continuum from prevention to treatment and palliative care.
List of papers published in 2022
Journal
1. Schüz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, Vaccarella S. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental health, 22:13, 2023
2. Tanaka H, Tanaka S, Togawa K, Katanoda K. Practical implications of the update to the 2015 Japan Standard Population: mortality archive from 1950 to 2020 in Japan. Journal of epidemiology, 2023
3. Kanehara R, Goto A, Watanabe T, Inoue K, Taguri M, Kobayashi S, Imai K, Saito E, Katanoda K, Iwasaki M, Ohashi K, Noda M, Higashi T. Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer. Journal of diabetes investigation, 13:1771-1778, 2022
4. Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. International journal of epidemiology, 51:1276-1290, 2022
5. Nguyen PT, Katanoda K, Saito E, Hori M, Nakayama T, Matsuda T. Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach. International journal of cancer, 151:20-32, 2022
6. Lau YK, Okawa S, Meza R, Katanoda K, Tabuchi T. Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tobacco control, 31:e50-e56, 2022
7. Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, Kantilal K, Katanoda K, Kenis C, Lu-Yao G, Matsuda T, Navarrete E, Nikita N, Puts M, Strohschein FJ, Morris EJA. International trends in cancer incidence in middle-aged and older adults in 44 countries. Journal of geriatric oncology, 13:346-355, 2022
8. Ito Y, Katanoda K, Yamamoto S, Hamajima N, Mochizuki Y, Matsuo K. Trends in smoking prevalence and attitude toward tobacco control among members of the JCA in 2004-2017. Cancer science, 113:1542-1547, 2022
9. Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Correction to: Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. International journal of epidemiology, 51:1355, 2022
10. Tanaka S, Palmer M, Katanoda K. Trends in cervical cancer incidence and mortality of young and middle adults in Japan. Cancer science, 113:1801-1807, 2022
11. Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, Ishihara J, Takachi R, Nagata C, Saito E, Goto A, Ueda K, Tanaka J, Hori M, Matsuda T. Burden of cancer attributable to modifiable factors in Japan in 2015. Global health & medicine, 4:26-36, 2022
12. Takenobu K, Yoshida S, Katanoda K, Kawakami K, Tabuchi T. Impact of workplace smoke-free policy on secondhand smoke exposure from cigarettes and exposure to secondhand heated tobacco product aerosol during COVID-19 pandemic in Japan: the JACSIS 2020 study. BMJ open, 12:e056891, 2022
13. Yoshida S, Okubo R, Katanoda K, Tabuchi T. Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation: the Japan COVID-19 and Society Internet Survey. Family practice, 39:883-890, 2022
14. Tanaka H, Nusselder WJ, Kobayashi Y, Mackenbach JP. Socioeconomic inequalities in self-rated health in Japan, 32 European countries and the United States: an international comparative study. Scandinavian journal of public health, 14034948221092285, 2022
15. Dhungel B, Wada K, Tanaka H, Gilmour S. Time to update the Japanese standard population for comparing mortality rates. Archives of public health = Archives belges de sante publique, 80:153, 2022
16. Yanagisawa-Sugita A, Sugiyama T, Ihana-Sugiyama N, Tanaka H, Imai K, Ueki K, Ohsugi M, Tamiya N, Kobayashi Y. Incidence of interventions for diabetic retinopathy and serious lower-limb complications and its related factors in patients with type 2 diabetes using a real-world large claims database. Diabetology international, 13:548-560, 2022
17. Smith J, Togawa K, Dresler C, Hawari F, Zain ZM, Stewart B, Warren GW, Sitas F. Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology. Cancer epidemiology, 79:102210, 2022
18. Ichikawa M, Inada H, Katanoda K, Nakahara S. Trend in alcohol-related crashes before and after the introduction of mandatory breath testing among commercial truck drivers. Journal of epidemiology, 2022
19. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machelek D, Ml Brotherton J, Hocking JS. Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis. Vaccine, 40:5971-5996, 2022
20. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tobacco control, tobaccocontrol-2022-057262, 2022
21. Kurokawa T, Ozaki A, Bhandari D, Kotera Y, Sawano T, Kanemoto Y, Kanzaki N, Ejiri T, Saito H, Kaneda Y, Tsubokura M, Tanimoto T, Katanoda K, Tabuchi T. Association between COVID-19 incidence and postponement or cancellation of elective surgeries in Japan until September 2020: a cross-sectional, web-based survey. BMJ open, 12:e059886, 2022
22. Kitajima T, Schüz J, Morita A, Ikeda W, Tanaka H, Togawa K, Gabazza EC, Taki M, Toriyabe K, Ikeda T, Sokejima S. Measurement of Intermediate Frequency Magnetic Fields Generated by Household Induction Cookers for Epidemiological Studies and Development of an Exposure Estimation Model. International journal of environmental research and public health, 19:11912, 2022
23. Kuurdor ED, Tanaka H, Kitajima T, Amexo JX, Sokejima S. Social Capital and Self-Rated Health: A Cross-Sectional Study among Rural Japanese Working Residents. International journal of environmental research and public health, 19:14018, 2022
24. Ozasa K, Katanoda K. A Special Issue on Fukushima Has Been Released a Decade After the Great East Japan Earthquake. Journal of epidemiology, 32:S1-S2, 2022
25. Katagiri R, Tabuchi T, Katanoda K. Socioeconomic and sociodemographic factors associated with food expense insufficiency during the COVID-19 pandemic in Japan. PloS one, 17:e0279266, 2022
26. Nguyen PT, Saito E, Katanoda K. Long-Term Projections of Cancer Incidence and Mortality in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2054: An Empirical Validation Approach. Cancers, 14:6076, 2022